Will Sonoco’s (SON) Removal From Russell Defensive Indices Change Its Core Investment Narrative?

Sonoco Products Company

Sonoco Products Company

SON

0.00

  • In late June 2026, Sonoco Products Company (NYSE: SON) was removed from both the Russell 1000 Value-Defensive Index and the Russell 1000 Defensive Index, signaling a reclassification of its profile within widely followed equity benchmarks.
  • This index removal could alter how quantitative and index-tracking funds treat Sonoco, potentially shifting its shareholder base and changing how the market evaluates its defensive packaging exposure.
  • Next, we’ll examine how Sonoco’s removal from key Russell defensive indices may influence its existing investment narrative and perceived risk profile.

Invest in the nuclear renaissance through our list of 89 elite nuclear energy infrastructure plays powering the global AI revolution.

Sonoco Products Investment Narrative Recap

To own Sonoco today, you need to believe in its core story around metal and paper packaging, cash generation, and steady execution on cost savings. The recent removal from Russell defensive indices may affect how some funds treat the stock, but it does not directly change the most important near term drivers, such as integration progress in Metal Packaging EMEA or the key risk from leverage, synergy delivery, and exposure to weaker demand in Europe and Asia.

The most relevant recent development here is Sonoco’s new US$300 million delayed draw term loan facility announced in March 2026, which adds flexibility but also highlights balance sheet risk. Against a backdrop of elevated net leverage, ongoing acquisition integration, and the need to extract over US$100 million in cost savings by 2026, both the index removal and this funding line sharpen the focus on how comfortably Sonoco can service its debt while maintaining dividends and necessary reinvestment.

Yet the real concern investors should be aware of is how quickly Sonoco can reduce leverage if...

Sonoco Products' narrative projects $7.7 billion revenue and $455.2 million earnings by 2029. This requires 1.1% yearly revenue growth and a decrease of about $153.8 million in earnings from $609.0 million today.

Uncover how Sonoco Products' forecasts yield a $60.89 fair value, a 8% upside to its current price.

Exploring Other Perspectives

SON 1-Year Stock Price Chart
SON 1-Year Stock Price Chart

While the index removal raises questions about Sonoco’s profile, the most optimistic analysts were previously assuming roughly US$8.0 billion of revenue and about US$587.3 million of earnings by 2029, which is a much brighter scenario than the consensus and shows how far opinions can diverge, especially if the Metal Packaging EMEA challenges play out differently than expected.

Explore 2 other fair value estimates on Sonoco Products - why the stock might be worth just $60.89!

Decide For Yourself

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

  • A great starting point for your Sonoco Products research is our analysis highlighting 3 key rewards and 4 important warning signs that could impact your investment decision.
  • Our free Sonoco Products research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Sonoco Products' overall financial health at a glance.

Curious About Other Options?

Don't miss your shot at the next 10-bagger. Our latest stock picks just dropped:

  • Capitalize on the AI infrastructure supercycle with our selection of the 52 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
  • Uncover the next big thing with 20 elite penny stocks that balance risk and reward.
  • AI is about to change healthcare. These 40 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.